Association Between the Dietary Inflammatory Index (DII) and Drug-Induced Liver Injury (DILI) in Patients with Drug-Resistant Tuberculosis: As Assessed for Causality Using the Updated RUCAM as Global Gold Standard

Background/Objectives: Treatment for drug-resistant tuberculosis involves a long duration and a heavy burden of drug-induced hepatotoxicity; drug-induced liver injury (DILI) is a significant issue affecting treatment safety. The Dietary Inflammation Index (DII) quantifies the pro-inflammatory potential of the diet, but evidence linking it to the risk of DILI in patients with drug-resistant tuberculosis is limited. This study aimed to investigate the relationship between DII and the risk of treatment-related liver injury in patients with drug-resistant tuberculosis. Methods: A prospective cohort of patients with drug-resistant tuberculosis was established at Hunan Provincial Chest Hospital, with a 6-month follow-up period during which liver function was assessed monthly. DILI was identified based on liver function abnormalities and causality was assessed using the Roussel Uclaf Causality Assessment Method (RUCAM), with a RUCAM score > 3 considered indicative of DILI. The Dietary Inflammatory Index (DII) was calculated using a semi-quantitative food frequency questionnaire, and participants were classified into anti-inflammatory, neutral, and pro-inflammatory groups using K-means clustering. Logistic regression was used to evaluate the association between DII and DILI after adjustment for potential confounders, including age, sex, BMI, smoking, alcohol consumption, and medication use. L1 regularization, restricted cubic spline analysis, and subgroup analyses were further performed to assess the robustness and potential nonlinear patterns of the association. Results: A total of 800 participants were enrolled; 729 completed follow-up, and 69 developed DILI, resulting in a cumulative incidence of 9.4%. The risk of DILI was significantly higher in the pro-inflammatory group than in the anti-inflammatory group: OR = 2.17 (95% CI: 1.17–4.05) in Model 1, and OR = 2.19 (95% CI: 1.16–4.14) after adjustment; For every 1-unit increase in DII, the risk of liver injury increased by approximately 29% (OR = 1.29, 95% CI: 1.08–1.54). Results from L1 regularization were consistent, and effect modification was observed at the levels of sex and age. Conclusions: A higher Dietary Inflammatory Index (DII) was an independent risk factor for antituberculosis treatment-related liver injury in patients with drug-resistant tuberculosis. The risk of drug-induced liver injury (DILI) in the pro-inflammatory dietary group was approximately twice that in the anti-inflammatory dietary group. Identifying and modifying pro-inflammatory dietary patterns may help reduce the risk of DILI and improve the safety of antituberculosis treatment.

Authors

Institutions

Publication Details

Journal
Nutrients
Published
2026-11-16
DOI
https://doi.org/10.3390/nu18223806
Primary Topic
Drug-Induced Hepatotoxicity and Protection
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Association Between the Dietary Inflammatory Index (DII) and Drug-Induced Liver Injury (DILI) in Patients with Drug-Resistant Tuberculosis: As Assessed for Causality Using the Updated RUCAM as Global Gold Standard

Mengshi Chen, Fan Xia, Ziyu Ma, Wen-Yi Yu et al.
2 links
Nutrients
Drug-Induced Hepatotoxicity and Protection
article

Association Between the Dietary Inflammatory Index (DII) and Drug-Induced Liver Injury (DILI) in Patients with Drug-Resistant Tuberculosis: As Assessed for Causality Using the Updated RUCAM as Global Gold Standard

Mengshi Chen, Fan Xia, Ziyu Ma, Wen-Yi Yu, Yu Guan, Cong Huang
article en

Abstract

Background/Objectives: Treatment for drug-resistant tuberculosis involves a long duration and a heavy burden of drug-induced hepatotoxicity; drug-induced liver injury (DILI) is a significant issue affecting treatment safety. The Dietary Inflammation Index (DII) quantifies the pro-inflammatory potential of the diet, but evidence linking it to the risk of DILI in patients with drug-resistant tuberculosis is limited. This study aimed to investigate the relationship between DII and the risk of treatment-related liver injury in patients with drug-resistant tuberculosis. Methods: A prospective cohort of patients with drug-resistant tuberculosis was established at Hunan Provincial Chest Hospital, with a 6-month follow-up period during which liver function was assessed monthly. DILI was identified based on liver function abnormalities and causality was assessed using the Roussel Uclaf Causality Assessment Method (RUCAM), with a RUCAM score > 3 considered indicative of DILI. The Dietary Inflammatory Index (DII) was calculated using a semi-quantitative food frequency questionnaire, and participants were classified into anti-inflammatory, neutral, and pro-inflammatory groups using K-means clustering. Logistic regression was used to evaluate the association between DII and DILI after adjustment for potential confounders, including age, sex, BMI, smoking, alcohol consumption, and medication use. L1 regularization, restricted cubic spline analysis, and subgroup analyses were further performed to assess the robustness and potential nonlinear patterns of the association. Results: A total of 800 participants were enrolled; 729 completed follow-up, and 69 developed DILI, resulting in a cumulative incidence of 9.4%. The risk of DILI was significantly higher in the pro-inflammatory group than in the anti-inflammatory group: OR = 2.17 (95% CI: 1.17–4.05) in Model 1, and OR = 2.19 (95% CI: 1.16–4.14) after adjustment; For every 1-unit increase in DII, the risk of liver injury increased by approximately 29% (OR = 1.29, 95% CI: 1.08–1.54). Results from L1 regularization were consistent, and effect modification was observed at the levels of sex and age. Conclusions: A higher Dietary Inflammatory Index (DII) was an independent risk factor for antituberculosis treatment-related liver injury in patients with drug-resistant tuberculosis. The risk of drug-induced liver injury (DILI) in the pro-inflammatory dietary group was approximately twice that in the anti-inflammatory dietary group. Identifying and modifying pro-inflammatory dietary patterns may help reduce the risk of DILI and improve the safety of antituberculosis treatment.

NutrientsVol. 18(22)
Central South University (CN), Hunan Provincial Center for Disease Control and Prevention (CN)
Central South University
Good health and well-being
Drug-Induced Hepatotoxicity and Protection
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon